OVERVIEW

22nd Pharmacovigilance 2020 is organized by Virtue Insight and will be held from Dec 09 - 10, 2020.

Description:
Bring together top pharmaceutical, biotechnology and regulatory representatives under one roof.

After the successful journey of a series of 22 Pharmacovigilance conferences, Virtue Insight is proud to announce its 22nd Pharmacovigilance 2020. We have been delivering the conference through close collaboration with the industry leaders for more than a decade. For the 2020 edition, the agenda includes a host of new and exciting features. Take a chance and make it count by attending our 22nd Pharmacovigilance 2020 to network with your peers, exchange expertise and experiences, and arm yourself with the latest information to take your department to the next level.

As per current market situation, the global pharmacovigilance market was approximately USD 3.87 billion in 2018 and is expected to generate around USD 8.33 billion by 2025, at a CAGR of around 11.6% between 2019 and 2025. This event will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. Get more from the event, with a broader scope bringing the whole communications value chain together.

It gives me great pleasure in welcoming all of you to the Virtue Insight’s 22nd Pharmacovigilance 2020. I wish and pray that all our efforts will be beneficial to our industries and to our all at large.

Focus On:
• Market analysis - Pharmacovigilance in 2022 - future horizons and efficiencies
• Regulations, Legal & Brexit Implications for the pharmacovigilance Industry
• Outsourcing in Pharmacovigilance- Best Practices, Challenges and key consideration
• New Technologies in Pharmacovigilance (AI/ Machine Learning, IoT, Blockchain & Big Data)
• PV Audit & Inspections - Knowing what is to be done
• RWE & RWD
• Documentation (RMPs, PSURs, PADERs, PBRERs)
• Quality, Safety and Signal Detection - Future of 2020
• Medical devices - Increasing safety perspective
• Case studies from various countries on the PV frameworks around the world
• Patient centric approach to help improve patient safety
• The developing regulatory framework in advanced and developing markets - EU, USA & ROW
• Be part of a major networking opportunity